One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...

Many patients with metastatic cancers receive therapy that is initially highly effective, often resulting in complete remission. However, cancer cells have a remarkable capacity to evolve resistance ...

Scientists report landmark "evolutionary double-bind" strategy to overcome treatment resistance in prostate cancer.

FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen receptor pathway inhibitor (ARPI)-treated, ...

In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.